vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and NPK International Inc. (NPKI). Click either name above to swap in a different company.
NPK International Inc. is the larger business by last-quarter revenue ($75.2M vs $43.6M, roughly 1.7× GRAIL, Inc.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs 14.0%). NPK International Inc. produced more free cash flow last quarter ($5.8M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 23.9%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
GRAL vs NPKI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $75.2M |
| Net Profit | $-99.2M | — |
| Gross Margin | — | 37.7% |
| Operating Margin | -285.4% | 16.7% |
| Net Margin | -227.5% | — |
| Revenue YoY | 14.0% | 30.7% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $-2.37 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $75.2M | ||
| Q3 25 | $36.2M | $68.8M | ||
| Q2 25 | $35.5M | $68.2M | ||
| Q1 25 | $31.8M | $64.8M | ||
| Q4 24 | $38.3M | $57.5M | ||
| Q3 24 | $28.7M | $44.2M | ||
| Q2 24 | $32.0M | $66.8M | ||
| Q1 24 | $26.7M | $49.0M |
| Q4 25 | $-99.2M | — | ||
| Q3 25 | $-89.0M | $5.7M | ||
| Q2 25 | $-114.0M | $8.7M | ||
| Q1 25 | $-106.2M | $10.0M | ||
| Q4 24 | $-97.1M | — | ||
| Q3 24 | $-125.7M | $-174.3M | ||
| Q2 24 | $-1.6B | $8.0M | ||
| Q1 24 | $-218.9M | $7.3M |
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 27.5% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 36.0% |
| Q4 25 | -285.4% | 16.7% | ||
| Q3 25 | -346.2% | 13.2% | ||
| Q2 25 | -446.9% | 17.0% | ||
| Q1 25 | -482.5% | 20.9% | ||
| Q4 24 | -358.0% | 20.2% | ||
| Q3 24 | -640.5% | 2.8% | ||
| Q2 24 | -5133.8% | 18.7% | ||
| Q1 24 | -851.1% | 14.2% |
| Q4 25 | -227.5% | — | ||
| Q3 25 | -245.8% | 8.2% | ||
| Q2 25 | -320.7% | 12.7% | ||
| Q1 25 | -333.6% | 15.4% | ||
| Q4 24 | -253.8% | — | ||
| Q3 24 | -438.7% | -394.3% | ||
| Q2 24 | -4958.8% | 12.0% | ||
| Q1 24 | -819.3% | 14.9% |
| Q4 25 | $-2.37 | $0.17 | ||
| Q3 25 | $-2.46 | $0.07 | ||
| Q2 25 | $-3.18 | $0.10 | ||
| Q1 25 | $-3.10 | $0.11 | ||
| Q4 24 | $-1.49 | $0.10 | ||
| Q3 24 | $-3.94 | $-1.99 | ||
| Q2 24 | $-51.06 | $0.09 | ||
| Q1 24 | $-7.05 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $5.1M |
| Total DebtLower is stronger | — | $16.9M |
| Stockholders' EquityBook value | $2.6B | $351.2M |
| Total Assets | $2.9B | $441.8M |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $5.1M | ||
| Q3 25 | $126.9M | $35.6M | ||
| Q2 25 | $127.4M | $26.0M | ||
| Q1 25 | $133.9M | $20.8M | ||
| Q4 24 | $214.2M | $17.8M | ||
| Q3 24 | $853.6M | $42.9M | ||
| Q2 24 | $958.8M | $35.1M | ||
| Q1 24 | $199.7M | $37.7M |
| Q4 25 | — | $16.9M | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $58.0M | ||
| Q1 24 | — | $77.4M |
| Q4 25 | $2.6B | $351.2M | ||
| Q3 25 | $2.2B | $333.9M | ||
| Q2 25 | $2.3B | $328.8M | ||
| Q1 25 | $2.4B | $326.9M | ||
| Q4 24 | $2.5B | $326.5M | ||
| Q3 24 | $2.6B | $316.5M | ||
| Q2 24 | $2.7B | $426.6M | ||
| Q1 24 | — | $421.6M |
| Q4 25 | $2.9B | $441.8M | ||
| Q3 25 | $2.6B | $404.5M | ||
| Q2 25 | $2.7B | $393.7M | ||
| Q1 25 | $2.8B | $390.0M | ||
| Q4 24 | $3.0B | $393.7M | ||
| Q3 24 | $3.1B | $389.6M | ||
| Q2 24 | $3.3B | $624.8M | ||
| Q1 24 | — | $640.8M |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $18.0M |
| Free Cash FlowOCF − Capex | $-63.9M | $5.8M |
| FCF MarginFCF / Revenue | -146.5% | 7.6% |
| Capex IntensityCapex / Revenue | 0.2% | 16.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $26.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $18.0M | ||
| Q3 25 | $-63.2M | $24.7M | ||
| Q2 25 | $-77.0M | $21.4M | ||
| Q1 25 | $-95.0M | $8.8M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-104.6M | $2.8M | ||
| Q2 24 | $-171.8M | $27.6M | ||
| Q1 24 | $-207.3M | $11.9M |
| Q4 25 | $-63.9M | $5.8M | ||
| Q3 25 | $-63.6M | $12.0M | ||
| Q2 25 | $-77.3M | $9.7M | ||
| Q1 25 | $-95.1M | $-1.2M | ||
| Q4 24 | — | $-17.7M | ||
| Q3 24 | $-105.6M | $-6.7M | ||
| Q2 24 | $-173.2M | $21.0M | ||
| Q1 24 | $-209.8M | $-1.9M |
| Q4 25 | -146.5% | 7.6% | ||
| Q3 25 | -175.8% | 17.4% | ||
| Q2 25 | -217.6% | 14.3% | ||
| Q1 25 | -298.6% | -1.8% | ||
| Q4 24 | — | -30.8% | ||
| Q3 24 | -368.4% | -15.2% | ||
| Q2 24 | -541.7% | 31.4% | ||
| Q1 24 | -785.3% | -3.9% |
| Q4 25 | 0.2% | 16.3% | ||
| Q3 25 | 1.1% | 18.5% | ||
| Q2 25 | 1.0% | 17.1% | ||
| Q1 25 | 0.2% | 15.5% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | 3.4% | 21.4% | ||
| Q2 24 | 4.3% | 9.9% | ||
| Q1 24 | 9.5% | 28.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.37× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.43× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
NPKI
| Rental Revenue | $34.8M | 46% |
| Products | $25.5M | 34% |
| Services | $14.9M | 20% |
